Atlas Trials

Angiogenesis Using VEGF-A165/bFGF Plasmid Delivered Percutaneously in No-option CAD Patients; a Controlled Trial

Clinical trial NCT00620217 · COMPLETED

Trial details

NCT number
NCT00620217
Sponsor
National Institute of Cardiology, Warsaw, Poland
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2004-12-01
Primary completion
2008-05-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.